Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

Antje StolzenburgKatharina LückerathSamuel SamnickMartin SpeerKatharina KneerJan-Stefan SchmidGötz Ulrich GrigoleitSusanne HofmannAmbros J BeerDonald BunjesStefan KnopAndreas K BuckHermann EinseleConstantin Lapa

Published in: European journal of nuclear medicine and molecular imaging (2018)

[18F]FDG-PET/CT before and shortly after allogeneic HCT is a powerful predictor for progression-free and overall survival in MM patients.

Keyphrases

end stage renal disease
ejection fraction
stem cell transplantation
chronic kidney disease
peritoneal dialysis
multiple myeloma
bone marrow
prognostic factors
cell proliferation
high dose
signaling pathway